CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Clinical trials for CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA) explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA) trials appear
Sign up with your email to follow new studies for CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a bone drug fix rare anemia? small trial begins
Disease control Recruiting nowThis early study tests whether zoledronic acid, a drug usually used for bone health, can help people with a rare inherited blood disorder called congenital dyserythropoietic anemia (CDA). The goal is to see if it can raise hemoglobin levels and reduce the need for blood transfusi…
Matched conditions: CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 07:58 UTC
-
New study aims to unlock personalized care for rare blood disorders
Knowledge-focused Recruiting nowThis study is for people with sickle cell disease or other rare anemias. Researchers want to use advanced blood tests and genetic analysis to better understand each person's condition. The goal is to predict disease severity and guide personalized treatment. About 200 participant…
Matched conditions: CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Knowledge-focused
Last updated May 26, 2026 07:55 UTC